These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6265123)

  • 21. Decreased neutrophil chemotaxis and chronic granulomatous disease.
    Kemp AS; Lo E; Vernon J; Robertson SE; Penny R
    Aust Paediatr J; 1984 May; 20(2):119-21. PubMed ID: 6466228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ascorbic acid nutriture on blood histamine and neutrophil chemotaxis in guinea pigs.
    Johnston CS; Huang SN
    J Nutr; 1991 Jan; 121(1):126-30. PubMed ID: 1992049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis.
    Johnston CS; Martin LJ; Cai X
    J Am Coll Nutr; 1992 Apr; 11(2):172-6. PubMed ID: 1578094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of polymorphonuclear leucocyte oxidative and bactericidal functions in chronic granulomatous disease with 4-amino-4'-hydroxylaminodiphenyl sulphone.
    Ismail G; Boxer LA; Allen JM; Baehner RL
    Br J Haematol; 1978 Oct; 40(2):219-29. PubMed ID: 708642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.
    Seligmann BE; Gallin JI
    J Clin Invest; 1980 Sep; 66(3):493-503. PubMed ID: 6249851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic granulomatous disease of childhood.
    Haddad HL; Beatty DW; Dowdle EB
    S Afr Med J; 1976 Dec; 50(52):2068-72. PubMed ID: 1013858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.
    Goetzl EJ; Wasserman SI; Gigli I; Austen KF
    J Clin Invest; 1974 Mar; 53(3):813-8. PubMed ID: 4273024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophil dysfunction and repeated infections: influence of levamisole and ascorbic acid.
    Rebora A; Dallegri F; Patrone F
    Br J Dermatol; 1980 Jan; 102(1):49-56. PubMed ID: 7378281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascorbic acid, neutrophil function, and the immune response.
    Leibovitz B; Siegel BV
    Int J Vitam Nutr Res; 1978; 48(2):159-64. PubMed ID: 357320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic granulomatous disease in two Chinese families.
    Lin YZ; Hsieh KH
    Asian Pac J Allergy Immunol; 1988 Dec; 6(2):121-8. PubMed ID: 3219159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-mediated cellular cytotoxicity induced by zymosan-activated serum.
    Dallegri F; Frumento G; Maggi AM; Ballestrero A; Muttini P; Patrone F
    J Clin Lab Immunol; 1984 Feb; 13(2):89-92. PubMed ID: 6726787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin C for the treatment of recurrent furunculosis in patients with imparied neutrophil functions.
    Levy R; Shriker O; Porath A; Riesenberg K; Schlaeffer F
    J Infect Dis; 1996 Jun; 173(6):1502-5. PubMed ID: 8648230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophyl function in children with chondrodystrophia calcificans congenita: evidence for defective chemotaxis.
    De Martino M; Vierucci A; Rossi ME; Galluzzi F; Salti R; La Cauza C
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):268-72. PubMed ID: 6639780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the oxidative metabolic burst in the antibody-dependent cellular cytotoxicity mediated by neutrophil polymorphonuclears.
    Dallegri F; Frumento G; Minervini F; Muttini P; Patrone F
    Exp Hematol; 1982 Nov; 10(10):859-66. PubMed ID: 6295791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cefotaxime on neutrophil and lymphocyte functions.
    Van Rensburg CE; Anderson R; Eftychis HA; Jooné GK
    S Afr Med J; 1983 Sep; 64(10):346-8. PubMed ID: 6310802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
    Naderi beni F; Fattahi F; Mirshafiey A; Ansari M; Mohsenzadegan M; Movahedi M; Pourpak Z; Moin M
    Int Immunopharmacol; 2012 Apr; 12(4):689-93. PubMed ID: 22330085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic granulomatous disease: studies of a family with impaired neutrophil chemotactic, metabolic and bactericidal function.
    Clark FA; Klebanoff SJ
    Am J Med; 1978 Dec; 65(6):941-8. PubMed ID: 742630
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.
    el-Hag A; Clark RA
    J Immunol; 1987 Oct; 139(7):2406-13. PubMed ID: 2821114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hemoglobin, hematin, and iron on neutrophil inactivation in superoxide generating systems.
    Kim YM; Yamazaki I; Piette LH
    Arch Biochem Biophys; 1994 Mar; 309(2):308-14. PubMed ID: 8135543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.